about
Antimycotic resistance - Approach from a One Health Perspective (MYCOS)

The primary focus of MYCOS is to understand the consequences of the dual use of antifungals in both human medicine and agriculture, from 'field to clinic'.

Vision. Guided by a One Health perspective interconnecting human, animal, and environmental health, MYCOS - Antimycotic resistance - Approach from a One Health Perspective - seeks to unravel the complexities of antifungal drug resistance and the composition of the microbiome across basic, translational, and clinical sciences. Through integrating environmental, physiological, genetic, computational, and clinical approaches, the overall goal of MYCOS is to advance human health, foster sustainable agriculture, and promote antifungal stewardship. MYCOS also aims to generate novel, innovative, and timely findings regarding antimicrobial resistance. Simultaneously, it will educate a new generation of scientists through an interdisciplinary, tailored PhD training program, guided by a highly dedicated consortium of natural and medical scientists from the Medical University of Innsbruck (MUI) and University of Innsbruck (UIBK).

Mission. At MYCOS, our mission is to be at the forefront of research on antimycotic resistance, using cutting-edge basic, translational, and clinical science. By fostering a diverse network of PhD students and scientists, we encourage collaboration and innovation in exploring the complex ramifications of antifungal dual usage in human medicine and agriculture. We aim to comprehensively understand the consequences in both clinical and environmental settings, and to identify significant links and interactions to antimycotic resistance. Guided by a One Health perspective, we strive to unravel the complexities of antifungal drug resistance (resistomes) and the composition of the mycobiome. Our commitment to interdisciplinary collaboration and cutting-edge research empowers us to generate novel data, develop alternative treatment strategies, and disseminate knowledge to promote multi-sectoral responses to public health threats.

Prof. Lackner recorded a Podcast regarding this topic (available in German): 'Resistenzforschung und Diagnostikforschung'

Benefits
  • provides a high-quality PhD training program
  • combines scientific originality, a unique inter- and multi-disciplinary faculty and cutting-edge training in a One Health perspective
  • offers academically driven young scientists in medical mycology research as MYCOS faculty
  • facilitates inter- and cross-institutional research (MUI and UIBK)
  • combines basic, translational, and clinical research
  • applies novel methods and technologies
  • introduces laboratory rotations of PhD candidates to gain a broad range of scientific skills
  • builds bridges and networks for future competitive research
Antimycotic resistance - Approach from a One Health Perspective (MYCOS)

The primary focus of MYCOS is to understand the consequences of the dual use of antifungals in both human medicine and agriculture, from 'field to clinic'.

Vision. Guided by a One Health perspective interconnecting human, animal, and environmental health, MYCOS - Antimycotic resistance - Approach from a One Health Perspective - seeks to unravel the complexities of antifungal drug resistance and the composition of the microbiome across basic, translational, and clinical sciences. Through integrating environmental, physiological, genetic, computational, and clinical approaches, the overall goal of MYCOS is to advance human health, foster sustainable agriculture, and promote antifungal stewardship. MYCOS also aims to generate novel, innovative, and timely findings regarding antimicrobial resistance. Simultaneously, it will educate a new generation of scientists through an interdisciplinary, tailored PhD training program, guided by a highly dedicated consortium of natural and medical scientists from the Medical University of Innsbruck (MUI) and University of Innsbruck (UIBK).

Mission. At MYCOS, our mission is to be at the forefront of research on antimycotic resistance, using cutting-edge basic, translational, and clinical science. By fostering a diverse network of PhD students and scientists, we encourage collaboration and innovation in exploring the complex ramifications of antifungal dual usage in human medicine and agriculture. We aim to comprehensively understand the consequences in both clinical and environmental settings, and to identify significant links and interactions to antimycotic resistance. Guided by a One Health perspective, we strive to unravel the complexities of antifungal drug resistance (resistomes) and the composition of the mycobiome. Our commitment to interdisciplinary collaboration and cutting-edge research empowers us to generate novel data, develop alternative treatment strategies, and disseminate knowledge to promote multi-sectoral responses to public health threats.

Prof. Lackner recorded a Podcast regarding this topic (available in German): 'Resistenzforschung und Diagnostikforschung'


benefits:
  • provides a high-quality PhD training program
  • combines scientific originality, a unique inter- and multi-disciplinary faculty and cutting-edge training in a One Health perspective
  • offers academically driven young scientists in medical mycology research as MYCOS faculty
  • facilitates inter- and cross-institutional research (MUI and UIBK)
  • combines basic, translational, and clinical research
  • applies novel methods and technologies
  • introduces laboratory rotations of PhD candidates to gain a broad range of scientific skills
  • builds bridges and networks for future competitive research





contact

PROGRAM SPEAKER

Univ.-Prof. Dr. Michaela Lackner
Medical University of Innsbruck
Schöpfstrasse 41
A-6020 Innsbruck

Imprint

Partner
 
This project is funded by MUI and UIBK. Dummy Icons © Julia Solerti, büro54 Nutzungsrechte bei der Medizinischen Universität Innsbruck. Portrait pictures: MUI/Bullock.